Extended Data Fig. 1: NABUCCO study design. | Nature Medicine

Extended Data Fig. 1: NABUCCO study design.

From: High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial

Extended Data Fig. 1

Cohort 1 is shown at the top, cohort 2A and cohort 2B are shown at the bottom. Arrows correspond with timing of study procedures and apply to all cohorts. Peripheral blood mononuclear cells (PBMCs), urine and plasma samples were collected <24 hours prior to corresponding treatment cycle or radical surgery. C1/2/3: first, second and third treatment cycle.

Back to article page